Hostname: page-component-7bb8b95d7b-qxsvm Total loading time: 0 Render date: 2024-09-05T17:55:13.429Z Has data issue: false hasContentIssue false

Conversion disorder misdiagnosed as epilepsy for 12 years, treated successfully with fluoxetine - Case report

Published online by Cambridge University Press:  16 April 2020

F. Elezi
Affiliation:
Department of Psychiatry, Univesity Hospital Center, Tirana, Albania
A. Braho
Affiliation:
Department of Psychiatry, Univesity Hospital Center, Tirana, Albania
E. Sotiri
Affiliation:
Department of Psychiatry, Univesity Hospital Center, Tirana, Albania
D. Dobi
Affiliation:
Department of Neurology, Univesity Hospital Center, Tirana, Albania

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

This case report suggests that Conversion Disorder may take years to become evident, so this diagnosis may place the clinician in difficulties and sometimes in misdiagnosis.

Method and results

A 39 years old woman admitted in Neurology Department (September 2005) to determine the nature of her seizures and other motor symptoms. The first symptoms appeared 12 years ago after marital conflicts. Some days later she presented motor symptoms such as, impaired coordination and balance, “epileptic” seizures and convulsions. She was diagnosed as suffering from Epilepsy and was treated with antiepileptic drugs for many years. During last year she presented a variation of motor symptoms, seizures, convulsions and some sensory symptoms, loss of touch (in the left side of the body), and because of instability. Neurological and laboratory examinations ruled out neurological disorders including epilepsy (normal EEG and CT). Psychiatric consultation followed.We realized that our patient met the diagnostic criteria (DSM-IV) for conversion disorder. Gradually, we discontinued antiepileptic drugs and began to treat with fluoxetine at maximum dose 40mg/day. Three months later she was released from previous symptoms, so we continued to treat with 20 mg/day for ten subsequent months. At present days she lives without motor or sensory symptoms. The patient has provided us with a video registration of her “crisis” recorded by her brother.

Conclusions:

The clinicians should raise the awareness about this diagnosis. They have to be careful and improve knowledge about treatment and diagnostic techniques.

Type
Poster Session 2: Anxiety, Stress Related, Impulse and Somatoform Disorders
Copyright
Copyright © European Psychiatric Association 2007
Submit a response

Comments

No Comments have been published for this article.